Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting to read:%0A%0A {0} %0A%0A {1}

Silverstone sells Coomera healthcare development site for $9.4m

Mike Walsh • 24/07/2021

Vital Healthcare Property Trust (Vital), managed by NorthWest Healthcare Properties Management Limited, has acquired a significant development site in Coomera on the Gold Coast for $9.4 million. The site at 187-195 Foxwell Road is situated within the ‘Coomera Health Precinct’, earmarked by Queensland Heath as the location for a new public hospital to service one of South-East Queensland's fastest growing population centres.


Vital purchased the 100% freehold interest from developer, Silverstone Developments, who has initially purchased the property in 2018 for $2.83 million and had completed infrastructure works including access and service roads. Featuring a total site area of 20,131 sqm (2.01ha), the site maintains a prime position on the corner of Foxwell Road and George Alexander Way.


Coomera Outline


Silverstone Developments had also lodged an application for a medical/mixed-use development prior to the sale. Vital has indicated it will now undertake a master planning process for a 6,000 sqm medical office building as part of stage 1 development, pending approvals for the revised medical centre proposal.


The off-market transaction was managed exclusively by Cushman & Wakefield’s Middle Markets team Mike Walsh and Peter Court, on behalf of Silverstone Developments.


The acquisition forms part of several recent purchases made by Vital, including the four level, 147-bed private hospital in Epworth, Camberwell for $82.7m, and two other development sites in South-East Queensland for a total of $11.4m.


Silverstone Developments’ Development Manager, Luke O’Dwyer, said: “Silverstone made the strategic decision to divest the Coomera site to Vital so the business can focus on existing developments in the inner-city Brisbane market.”


Cushman & Wakefield’s Joint Head of Middle Markets, Mike Walsh, said: “With a lack of new core medical product being brought to market, we are seeing increased appetite from healthcare-based groups seeking quality development opportunities. Particularly within established healthcare precincts provide an opportunity to create projects suited to their portfolios.” 

“The deal represents the fourth healthcare related transaction Cushman & Wakefield has exclusively brokered on behalf of Silverstone in only the past 12 months, totalling in excess of $225 million,” Mr Walsh added.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Privacy & Cookies.
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All